Skip to content
Exosome Therapy USA is an information service. We are not a clinic, we treat no one, and nothing here is medical advice.No exosome product is FDA approvedPrices appear only with a date and a sourceThe waitlist is open while we verify clinics

Exosome vs PDRN: Two Skincare Terms Compared

Exosomes are particles that cells release. PDRN, short for polydeoxyribonucleotide, is a DNA-based ingredient. They are different things that now often sit together on one product label.

The evidence for both is preliminary, and we declare no winner.

Last reviewed October 15, 2026

Side by side

What each term means on a product page, with the evidence summarized from the sources below.
TopicExosomesPDRN
What it isTiny particles wrapped in a membrane that cells release, carrying proteins, fats and genetic materialPolydeoxyribonucleotide, fragments of DNA used as a skincare ingredient
What the label may say"Exosomes", "extracellular vesicles", sometimes with a source such as plant, milk or bacteria"PDRN", "sodium DNA"; the maker we read describes salmon DNA
EvidencePreliminary: 19 human studies in a 2026 review, mostly not randomizedSeven randomized trials with 183 participants in a 2026 review, small and varied
FDANo exosome product is FDA approvedWe make no regulatory claim about PDRN

What each one is

Exosomes belong to the family of extracellular vesicles: particles enclosed in a membrane that carry proteins, lipids and nucleic acids between cells. Many aesthetic products and studies call such preparations exosomes even when an exosome origin is not shown. (PMID 42353255)

PDRN is a DNA-derived ingredient. The Medicube page we read describes salmon DNA fragments, and lists "Sodium DNA" in the ingredient list of its PDRN exosome shot, next to extracellular vesicles and milk exosomes. (Medicube PDRN Pink Collagen Exosome Shot page)

What studies show

A 2026 systematic review of PDRN trials found seven randomized trials with 183 participants. Four looked at skin rejuvenation. Overall they reported better wrinkle-related outcomes, scar quality and satisfaction, with no serious treatment-related adverse events. The review mixes several indications, and its abstract does not state how the products were applied. The authors note small samples, varied protocols and a need for larger trials. (PMID 42572627)

A 2026 narrative review of PDRN after skin procedures describes the human evidence as a mix of randomized trials, cohort studies and split-face trials, with few randomized aesthetic trials, small samples and formulas that differ. (PMID 42299173)

For exosomes see the evidence guide. None of the studies we cite compares the two head to head.

What the rules say

For exosomes, the FDA said in 2019 that there are no FDA-approved exosome products. (FDA notice, December 6, 2019) We make no claim about the regulatory status of PDRN. For how the FDA treats skincare in general, see the FDA status guide.

Reading a label that has both

A bottle that lists both exosomes and PDRN is a blend, and any effect belongs to the whole formula. Check the full ingredient list, not just the front of the box. Our label guide shows how.

Quick answers

What is the difference between exosomes and PDRN?

Exosomes are membrane-wrapped particles released by cells. PDRN is a DNA-based ingredient. Some skincare products list both.

Which is better, exosomes or PDRN?

None of the studies we cite compares them head to head, so we cannot name one. The evidence for each is preliminary.

Sources

This page has not yet been reviewed by a licensed clinician. Sources are listed below. Last editorial check: October 15, 2026.

  1. 2026 narrative review of extracellular vesicles in aesthetic medicine, PubMed, PMID 42353255
  2. 2026 systematic review of PDRN trials, PubMed, PMID 42572627
  3. 2026 narrative review of PDRN after skin procedures, PubMed, PMID 42299173
  4. Medicube US, PDRN Pink Collagen Exosome Shot product page, read October 15, 2026
  5. FDA public safety notification on exosome products, December 6, 2019